IBRX
Price:
$5.895
Market Cap:
$5.81B
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amy...[Read more]
Industry
Biotechnology
IPO Date
2015-07-28
Stock Exchange
NASDAQ
Ticker
IBRX
According to ImmunityBio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.81B. This represents a change of 124.56% compared to the average of 2.59B of the last 4 quarters.
The mean historical Enterprise Value of ImmunityBio, Inc. over the last ten years is 2.66B. The current 5.81B Enterprise Value has changed 21.75% with respect to the historical average. Over the past ten years (40 quarters), IBRX's Enterprise Value was at its highest in in the March 2021 quarter at 9.36B. The Enterprise Value was at its lowest in in the December 2018 quarter at 367.14M.
Average
2.66B
Median
2.40B
Minimum
367.14M
Maximum
5.48B
Discovering the peaks and valleys of ImmunityBio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 295.38%
Maximum Annual Enterprise Value = 5.48B
Minimum Annual Increase = -73.83%
Minimum Annual Enterprise Value = 367.14M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 2.15B | -28.82% |
| 2023 | 3.01B | 13.90% |
| 2022 | 2.65B | -6.52% |
| 2021 | 2.83B | -47.07% |
| 2020 | 5.35B | 268.45% |
| 2019 | 1.45B | 295.38% |
| 2018 | 367.14M | -73.83% |
| 2017 | 1.40B | -25.36% |
| 2016 | 1.88B | -65.71% |
| 2015 | 5.48B | -49.61% |
The current Enterprise Value of ImmunityBio, Inc. (IBRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.60B
5-year avg
3.20B
10-year avg
2.66B
ImmunityBio, Inc.’s Enterprise Value is greater than Arcus Biosciences, Inc. (2.07B), greater than Denali Therapeutics Inc. (3.33B), greater than 89bio, Inc. (2.11B), greater than Cogent Biosciences, Inc. (5.67B), greater than Galapagos N.V. (1.80B), greater than Beam Therapeutics Inc. (2.87B), greater than Recursion Pharmaceuticals, Inc. (1.17B), greater than Liquidia Corporation (3.87B), greater than Agios Pharmaceuticals, Inc. (1.56B), greater than Viridian Therapeutics, Inc. (2.58B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.07B | $2.20B | |
| 3.33B | $3.37B | |
| 2.11B | $2.20B | |
| 5.67B | $5.73B | |
| 1.80B | $2.25B | |
| 2.87B | $2.99B | |
| 1.17B | $1.74B | |
| 3.87B | $3.83B | |
| 1.56B | $1.61B | |
| 2.58B | $2.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunityBio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ImmunityBio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ImmunityBio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for ImmunityBio, Inc. (IBRX)?
What is the 3-year average Enterprise Value for ImmunityBio, Inc. (IBRX)?
What is the 5-year average Enterprise Value for ImmunityBio, Inc. (IBRX)?
How does the current Enterprise Value for ImmunityBio, Inc. (IBRX) compare to its historical average?